Company Search:
Advanced Search
Sponsored Links
Tty Biopharm Company Limited Company Snapshot
Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other companies in this sector in Taiwan: Pharmally International Holding Company Ltd (2016 sales of 4.33 billion Taiwanese Dollars [US$146.63 million] ), Formosa Laboratories, Inc (3.19 billion Taiwanese Dollars [US$107.90 million] of which 100% was Active Pharmaceutical Ingredient), and Standard Chem. & Pharm. Co Ltd (3.67 billion Taiwanese Dollars [US$124.28 million] of which 64% was Standard).

Sales Analysis. Tty Biopharm Company Limited reported sales of 3.76 billion Taiwanese Dollars (US$127.23 million) for the year ending December of 2016. This represents an increase of 17.7% versus 2015, when the company's sales were 3.20 billion Taiwanese Dollars. The sales level in 2016 was fairly close to the level five years ago: in 2011, Tty Biopharm Company Limited had sales of 3.87 billion Taiwanese Dollars. Sales of Anti-Infection Drug saw an increase that was more than double the company's growth rate: sales were up 63.9% in 2016, from 310.06 million Taiwanese Dollars to 508.11 million Taiwanese Dollars. Tty Biopharm Company Limited also saw significant increases in sales in Other (up 43.4% to 17.09 million Taiwanese Dollars) . Not all segments of Tty Biopharm Company Limited experienced an increase in sales in 2016: sales of Mainland fell 8.3% to 64.70 million Taiwanese Dollars. (However, this segment's sales were only a very small portion of the company's overall sales). Tty Biopharm Company Limited also experienced decreases in sales in Cardiovascular and Gastrointestinal Drug (down 4.1% to 492.47 million Taiwanese Dollars) and Taipei Branch (down 0.7% to 205.16 million Taiwanese Dollars) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tty Biopharm Company Limited
  Stock Performance Chart for Tty Biopharm Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 104.50
(Figures in Taiwanese Dollars)
1 Week 5.0%   13 Weeks 2.0%  
4 Weeks 12.4%   52 Weeks 4.0%  
Tty Biopharm Company Limited Key Data:
  Ticker: 4105 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 3,760,717,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 25,983,925,000
  Fiscal Yr Ends: December Shares Outstanding: 248,650,000
  Share Type: Gu Closely Held Shares: 58,864,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.